Cargando…
Adeno-Associated Virus (AAV) - Based Gene Therapies for Retinal Diseases: Where are We?
Owing to their small size and safety profiles, adeno-associated viruses (AAVs) have become the vector of choice for gene therapy applications in the retina. In addition to the naturally occurring AAVs, several engineered variants with enhanced properties are being developed for experimental and ther...
Autores principales: | Ail, Divya, Malki, Hugo, Zin, Emilia A, Dalkara, Deniz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239239/ https://www.ncbi.nlm.nih.gov/pubmed/37274131 http://dx.doi.org/10.2147/TACG.S383453 |
Ejemplares similares
-
Immune Responses to Gene Editing by Viral and Non-Viral Delivery Vectors Used in Retinal Gene Therapy
por: Ren, Duohao, et al.
Publicado: (2022) -
Systemic and local immune responses to intraocular AAV vector administration in non-human primates
por: Ail, Divya, et al.
Publicado: (2022) -
Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
por: Naso, Michael F., et al.
Publicado: (2017) -
Adeno‐associated virus (AAV)-based gene therapy for glioblastoma
por: Xu, Xin, et al.
Publicado: (2021) -
Improved adeno-associated virus (AAV) serotype 1 and 5 vectors for gene therapy
por: Sen, Dwaipayan, et al.
Publicado: (2013)